SCHEMBL867457

SCHEMBL867457

O=C1N=CC=C(O)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7409317 0.83
SCHEMBL14830653 0.68
SCHEMBL14830503 0.68
SCHEMBL14949882 0.66
SCHEMBL235760 0.66 KDM4E (0.40)
SCHEMBL14829862 0.64
SCHEMBL14829441 0.64
SCHEMBL14829815 0.64 HKDC1 (0.39)
SCHEMBL7269352 0.63
SCHEMBL7569561 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077852-A1 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS CARLO GHISALBERTI (BR) 2012-03-29 US claimed
US-20060135448-A1 Hydroxypyridinones for the local treatment of skin microcirculatroy disorders RELIVIA S.R.L. (IT) 2006-06-22 US claimed
EP-1567156-A2 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS RELIVIA SRL (IT) 2005-08-31 EP claimed
WO-2004045609-A2 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS RELIVIA SRL (IT) 2004-06-03 WO claimed
EP-2760834-B1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2016-11-16 EP disclosed
US-8933235-B2 Pyridinedione carboxamide inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-01-13 US disclosed
US-20140235673-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2014-08-21 US disclosed
EP-2760834-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE Bristol-Myers Squibb Company (US) 2014-08-06 EP disclosed
WO-2013048930-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-04 WO disclosed
US-20120077852-A1 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS CARLO GHISALBERTI (BR) 2012-03-29 US disclosed
US-20120077852-A1 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS CARLO GHISALBERTI (BR) 2012-03-29 US disclosed
US-7893024-B2 Enhancement of iron chelation therapy CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) 2011-02-22 US disclosed
US-20060135448-A1 Hydroxypyridinones for the local treatment of skin microcirculatroy disorders RELIVIA S.R.L. (IT) 2006-06-22 US disclosed
US-20060135448-A1 Hydroxypyridinones for the local treatment of skin microcirculatroy disorders RELIVIA S.R.L. (IT) 2006-06-22 US disclosed
EP-1567156-A2 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS RELIVIA SRL (IT) 2005-08-31 EP disclosed
EP-1567156-A2 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS RELIVIA SRL (IT) 2005-08-31 EP disclosed
WO-2004045609-A3 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS GHISALBERTI CARLO (BR) 2004-09-16 WO disclosed
WO-2004045609-A2 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS RELIVIA SRL (IT) 2004-06-03 WO disclosed
WO-2004045609-A2 HYDROXYPYRIDINONES FOR THE LOCAL TREATMENT OF SKIN MICROCIRCULATORY DISORDERS RELIVIA SRL (IT) 2004-06-03 WO disclosed
US-20030220230-A1 Enhancement of iron chelation therapy CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) 2003-11-27 US disclosed